BerandaCYCCP • NASDAQ
add
Cyclacel Pharmaceuticals Inc Conv. Pref. Shrs
Tutup sebelumnya
$5,30
Rentang tahun
$3,20 - $17,00
Kapitalisasi pasar
8,03 jt USD
Volume Rata-Rata
1,18 rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 5,04 jt | 14,87% |
Laba bersih | -81,00 rb | 97,25% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -5,03 jt | -15,66% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,45 jt | 23,30% |
Total aset | 3,73 jt | -39,43% |
Total liabilitas | 672,00 rb | -91,97% |
Total ekuitas | 3,06 jt | — |
Saham yang beredar | 22,27 jt | — |
Harga terhadap nilai buku | 22,08 | — |
Tingkat pengembalian aset | -321,67% | — |
Tingkat pengembalian modal | -2.807,13% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -81,00 rb | 97,25% |
Kas dari operasi | -3,25 jt | -572,26% |
Kas dari investasi | — | — |
Kas dari pembiayaan | 3,65 jt | 4.715,19% |
Perubahan kas bersih | 313,00 rb | 153,97% |
Arus kas bebas | -6,81 jt | -2.179,72% |
Tentang
Cyclacel Pharmaceuticals Inc. is a biotechnology firm based in Dundee, Scotland, and Short Hills, New Jersey, developing cancer drugs and treatments. Cyclacel was founded in 1996 by David Lane, Merlin Ventures and Cancer Research Campaign Technology with the University of Dundee and the University of Glasgow. Wikipedia
Didirikan
13 Agu 1996
Kantor pusat
Situs
Karyawan
12
